Subjects: INFLUENZA (EPIDEMIOLOGIA), VACINAS VIRAIS, AUTOANTICORPOS, VACINAÇÃO, FÁRMACOS IMUNOSSUPRESSORES
ABNT
SHINJO, Samuel Katsuyuki et al. Pandemic unadjuvanted influenza A (H1N1) vaccine in dermatomyositis and polymyositis: Immunogenicity independent of therapy and no harmful effect in disease. Vaccine, v. 31, n. 1, p. 202\2013206, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2012.10.063. Acesso em: 22 ago. 2024.APA
Shinjo, S. K., Moraes, J. C. B. de, Levy-Neto, M., Aikawa, N. E., Ribeiro, A. C. de M., Saad, C. G. S., et al. (2012). Pandemic unadjuvanted influenza A (H1N1) vaccine in dermatomyositis and polymyositis: Immunogenicity independent of therapy and no harmful effect in disease. Vaccine, 31( 1), 202\2013206. doi:10.1016/j.vaccine.2012.10.063NLM
Shinjo SK, Moraes JCB de, Levy-Neto M, Aikawa NE, Ribeiro AC de M, Saad CGS, Precioso A, Silva CA, Bonfá ESD de O. Pandemic unadjuvanted influenza A (H1N1) vaccine in dermatomyositis and polymyositis: Immunogenicity independent of therapy and no harmful effect in disease [Internet]. Vaccine. 2012 ; 31( 1): 202\2013206.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.vaccine.2012.10.063Vancouver
Shinjo SK, Moraes JCB de, Levy-Neto M, Aikawa NE, Ribeiro AC de M, Saad CGS, Precioso A, Silva CA, Bonfá ESD de O. Pandemic unadjuvanted influenza A (H1N1) vaccine in dermatomyositis and polymyositis: Immunogenicity independent of therapy and no harmful effect in disease [Internet]. Vaccine. 2012 ; 31( 1): 202\2013206.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.vaccine.2012.10.063